Collectively, these observations underscore i) a broader pro-tumorigenic role for CD200 in the tumor microenvironment and ii) potential pleiotropic mechanisms adopted by CD200 to mediate tumor cell survival, invasion and metastasis that may be difficult to block via a monoclonal antibody treatment modality targeting a specific ectodomain region. The gene discussed is CD200; the disease is neoplasm.